Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Gujarat Inject (Kerala) Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Gujarat Inject (Kerala) Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Guj. Inject(Kera - EGM TO BE HELD ON 03.04.2025

    12 Mar 2025, 9:19PM EGM TO BE HELD ON 03.04.2025
  • Guj. Inject(Kera - Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday 18Th February, 2025 Pursuant To Reg

    18 Feb 2025, 8:43PM Outcome of the Board Meeting held on Tuesday 18th February, 2025 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) R
  • Guj. Inject(Kera - Board Meeting Intimation for Sub- Division/Split Of The Equity Shares Of The Company.

    13 Feb 2025, 10:37PM GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/02/2025 ,inter alia, to cons
  • Guj. Inject(Kera - Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, 05Th February 2025 Pursuant To Regul

    5 Feb 2025, 9:54PM Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Direct
  • Guj. Inject(Kera - Board Meeting Intimation for Sub- Division/Split Of The Equity Shares Of The Company.

    1 Feb 2025, 6:14PM GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2025 ,inter alia, to cons
  • Guj. Inject(Kera - Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended On December 31, 2024 Alon

    23 Jan 2025, 6:09PM Unaudited Financial Results of the Company for the quarter and nine months ended on December 31, 2024 along with Limited Review Report (Unmodified Opi
  • Guj. Inject(Kera - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. On January 23, 2025

    23 Jan 2025, 6:05PM In reference to captioned subject, we hereby inform you that the Board of Directors of the Company, in their Board Meeting held on today, i.e. on Janu
  • Guj. Inject(Kera has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024

    20 Jan 2025, 5:00PM As of December 2024, 100.00% owned by Public. <p align=justify>
  • Guj. Inject(Kera - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    17 Jan 2025, 3:35PM Certificate under Regulation 74(5) of SEBI(Depositories and Participants) Regulation, 2018 for the quarter ender December 31, 2024

Key fundamentals

Evaluate the intrinsic value of Gujarat Inject (Kerala) Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 8.5453 -0.2298 -0.1441 -0.1888 -0.1862
Liabilities 8.5453 -0.2298 -0.1441 -0.1888 -0.1862
Equity 11.2923 4.8848 4.8848 4.8848 4.8848
Gross Profit 0.0448 -0.3771 -0.0452 -0.1134 -0.005
Net Profit 0.0827 0.041 0.0022 -0.1052 0.0002
Cash From Operating Activities -6.0276 0.0526 -0.0002 -0.1067 0.0002
NPM(%) 1.42 23.59 9.77 -911.24 0
Revenue 5.7883 0.1738 0.0226 0.0115 0
Expenses 5.7434 0.5509 0.0678 0.1249 0.005
ROE(%) 0.91 0.45 0.02 -1.16 0

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Gujarat Inject (Kerala) Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 809.25 -0.64 11.41 15.91 1321.50 1.42
Lotus Eye Hospital and Institute Ltd 58.19 1.50 237.75 57.96 14.01 0.88
Bharat Immunological and Biologicals Corporation Ltd 21.32 -1.30 0.00 120.34 -39.50 0.00
Astec Lifesciences Ltd 654.90 -5.39 0.00 54.65 -239.30 0.00

Company Info

Gujarat Inject (Kerala) Limited (GIKL) was incorporated on 7th January, 1991 and obtained Certificate for Commencement of Business on 14th February, 1991. The Company has been jointly promoted by the Kerala State Industrial Development Corporation Limited(KSIDC), a wholly owned subsidiary of Government of Kerala Undertaking and Gujarat Inject Limited (GIL) and its associates. GIL is a profit making dividend paying company. The Company has received SIA Registration to manufacture intravenous solutions at Puddussey East, Kanjikode, in Palghat District in Kerala. b) MAIN OBJECTS OF THE COMPANY The main object of the Company as set out fully in the Memorandum of Association of the Company are to produce, manufacture, buy, sell, import, export, stock, distribute and deal in all kinds of pharmaceuticals products including bulk drugs and formulation chemicals, medicinal preparation,intravenous fluids, infusion and transfusion solutions, vitamin and non vitamin tablets, capsules, liquids and also medical equipments/instruments such as disposable plastic bottles, surgical sets, infusion and transfusion sets, disposable syringes diagnostic kits. The immediate object of the Company is to set up a project for manufacture of intravenous (IV) Fluids solutions in aspectic bottles. Gujarat Inject (Kerala) Limited (GIKL) is promoted in the joint sector by Gujarat Inject Limited (GIL), Baroda and its associates along with the Kerala State Industrial Development Corporation Limited (KSIDC) a wholly owned subsidiary of the Government of Kerala.

Gujarat Inject (Kerala) Limited (GIKL) was incorporated on 7th January, 1991 and obtained Certificate for Commencement of Business on 14th February, 1991. The Company has been jointly promoted by the Kerala State Industrial Development Corporation Limited(KSIDC), a wholly owned subsidiary of Government of Kerala Undertaking and Gujarat Inject Limited (GIL) and its associates. GIL is a profit making dividend paying company. The Company has received SIA Registration to manufacture intravenous solutions at Puddussey East, Kanjikode, in Palghat District in Kerala. b) MAIN OBJECTS OF THE COMPANY The main object of the Company as set out fully in the Memorandum of Association of the Company are to produce, manufacture, buy, sell, import, export, stock, distribute and deal in all kinds of pharmaceuticals products including bulk drugs and formulation chemicals, medicinal preparation,intravenous fluids, infusion and transfusion solutions, vitamin and non vitamin tablets, capsules, liquids and also medical equipments/instruments such as disposable plastic bottles, surgical sets, infusion and transfusion sets, disposable syringes diagnostic kits. The immediate object of the Company is to set up a project for manufacture of intravenous (IV) Fluids solutions in aspectic bottles. Gujarat Inject (Kerala) Limited (GIKL) is promoted in the joint sector by Gujarat Inject Limited (GIL), Baroda and its associates along with the Kerala State Industrial Development Corporation Limited (KSIDC) a wholly owned subsidiary of the Government of Kerala.

Read More

Parent Organisation

Gujarat Inject (Kerala) Ltd.

Founded

07/01/1991

Managing Director

NSE Symbol

FAQ

The current price of Gujarat Inject (Kerala) Ltd is

The 52-week high for Gujarat Inject (Kerala) Ltd is

The market capitalization of Gujarat Inject (Kerala) Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Gujarat Inject (Kerala) Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Gujarat Inject (Kerala) Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Gujarat Inject (Kerala) Ltd shares.

The CEO of Gujarat Inject (Kerala) Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT